Peer-influenced content. Sources you trust. No registration required. This is HCN.
British Medical Journal (The BMJ)
“Selecting a GLP-1 receptor agonist over another antihyperglycemic drug could plausibly confer ancillary benefit” in patients at high risk for or living with an SUD. — Study authors
Endocrinology, Diabetes, Metabolism March 18th 2026
The Canadian Journal of Psychiatry
“The prevalence of internalizing problems increased more rapidly among Canadians who used cannabis compared to those who do not.” — Study authors
Psychiatry March 18th 2026
The American Journal of Nursing (AJN)
Patients seeking ketamine treatment have often spent years seeking to treat their mental health symptoms, and out of that desperation, seek out care without thoroughly vetting their options or practitioners.
Community/Public Health Nursing February 26th 2026
Psychiatry Advisor
Among adults using prescription stimulants, amphetamine users showed threefold higher misuse prevalence and doubled prescription stimulant use disorder rates compared to methylphenidate users, indicating significant differential abuse liability between medication classes.
Family Medicine/General Practice May 28th 2025
MedCentral
With more potent forms of opioids on the street, overdoses from illicit drugs are at an all-time high and withdrawal from them is often more severe.
Pain Medicine February 20th 2025
Epoch Health
Drug poisoning has emerged as the leading cause of death among young adults since 2014, with nearly 80% of deaths in 2022 involving both heroin and fentanyl.
Cardiology February 10th 2025